Leflunomide Metabolite Ethyl Analog
✓
100 % Datengenauigkeit
Wissenschaftlicher Support rund um die Uhr
⬡
0 % Toleranz bei der Produktqualität

Lagerstandorte

  • New Jersey, USA
  • Czech Republic, EU
  • Mumbai, India

* Vorbehaltlich Verfügbarkeit

Dokumentation

MSDS herunterladen

Beispiel-COA herunterladen

Enthält: HPLC, MASS/LC-MS, 1H-NMR, FT-IR, Gehalt, Structure Elucidation Report (SER) sowie zusätzliche analytische Daten je nach Produkt.

2734292-21-6Leflunomide Metabolite Ethyl Analog

● Auf Lager

Katalog-Nr.::VL1060017
CAS-Nr.::2734292-21-6
Summenformel::C13H11F3N2O2
Molare Masse::284.24

Zusätzliche Informationen zu CAS 2734292-21-6

Parent drug

Leflunomide

IUPAC-Name

(Z)-2-cyano-3-hydroxy-N-(4-(trifluoromethyl)phenyl)pent-2-enamide

Pharmakopöe-Synonyme

N/A

Other Synonyms

N/A

SMILES

CC/C(O)=C(C#N)/C(NC1=CC=C(C(F)(F)F)C=C1)=O

Inchl

InChI=1S/C13H11F3N2O2/c1-2-11(19)10(7-17)12(20)18-9-5-3-8(4-6-9)13(14,15)16/h3-6,19H,2H2,1H3,(H,18,20)/b11-10-

Beschreibung

The compound Leflunomide Metabolite Ethyl Analog is a highly characterized reference material that meets stringent regulatory standards, including those set by USP, EMA, JP, and BP. This product is essential for a variety of applications, such as analytical method development, method validation (AMV), and Quality Control (QC), particularly in the context of Leflunomide production. It is suitable for use in both Abbreviated New Drug Applications (ANDA) and New Drug Applications (NDA). Additionally, the product comes with a detailed Structure Elucidation Report (SER), ensuring its precision and reliability for comprehensive analytical use.

Angebot anfordern

„*“ zeigt erforderliche Felder an

Dieses Feld dient zur Validierung und sollte nicht verändert werden.
Products quotation
Name
Url